Newswise — Researchers at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas Medical Branch at Galveston (UTMB Health) have discovered a potential new antibody therapy for COVID-19. The study was published in Nature Communications.

Antibodies are proteins that allow the body to fight viruses such as SARS-CoV-2, the virus that causes COVID-19.

“Antibody-based therapy is a viable drug modality for the treatment of COVID-19,” said Zhiqiang An, PhD, professor and Robert A. Welch Distinguished University Chair in Chemistry at McGovern Medical School at UTHealth, and faculty member at MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences. “By leveraging the unique antibody drug discovery capabilities at UTHealth and the strong virology expertise at UTMB, we started to generate SARS-CoV-2-neutralizing antibodies in February of last year. The lead antibody combination out of our research is now being developed with a biotech partner for the treatment of COVID-19.”

Image by Michal Jarmoluk from Pixabay

Read more…